...
首页> 外文期刊>The Journal of biological chemistry >Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis
【24h】

Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis

机译:胆固醇酯转移蛋白表达部分衰减SR-BI受体缺乏对胆固醇代谢和动脉粥样硬化的不利影响

获取原文
           

摘要

Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phopholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.
机译:清除剂受体SR-BI显着有助于小鼠HDL胆固醇代谢和血肿性。然而,由于胆汁甾醇酯转移蛋白(CETP)活性,SR-BI的作用可能不会在人类中发音。为了解决CETP表达对与SR-BI缺乏相关的不良反应的影响,我们用CETP转基因小鼠跨越SR-BI有条件敲除小鼠模型。 CETP几乎完全恢复了SR-BI缺陷小鼠中的异常HDL-C分布。然而,它并未将升高的血浆无血浆的总胆固醇比率与肝脏SR-BI缺乏的特征正常化。通过CETP部分恢复在SR-BI的小鼠肝脏中观察到的红细胞和血小板计数异常,但升高的红细胞胆固醇与Phopholipid比率保持不变。完全删除SR-BI与肾上腺胆固醇储存减少相关,而肝脏SR-BI缺乏导致肾上腺胆固醇含量显着增加。在两种小鼠模型中,CETP对肾上腺胆固醇代谢没有影响。在饮食诱导的动脉粥样硬化研究中,与对照相比,肝脏SR-BI缺乏率加速在CETP表达(4倍)和非CETP表达(8倍)小鼠中的主动脉脂质病变。受损的巨噬细胞在肝脏缺乏SR-BI缺乏的小鼠中粪便中的抗胆固醇转运,这对CETP没有纠正,最有可能通过这种动脉粥样硬化易感性增加。最后,SR-BI肝脏缺乏和完全缺陷的小鼠中动脉粥样硬化负荷的比较证明了SR-BI是否存在肝脏组织中的动脉保护活性,无论是否存在CETP。这些调查结果支持争夺性SR-BI途径促进胆固醇代谢和动脉粥样硬化易感性的独特方式,即使在CETP存在下也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号